Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression: Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012

M. Chavez-Macgregor; V. Valero

doi:10.1016/j.breastdis.2013.04.044

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression: Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012

M. Chavez-Macgregor, V. Valero

Breast Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	143-144
Number of pages	2
Journal	Breast Diseases
Volume	24
Issue number	2
DOIs	https://doi.org/10.1016/j.breastdis.2013.04.044
State	Published - 2013

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/j.breastdis.2013.04.044

Cite this

Chavez-Macgregor, M., & Valero, V. (2013). Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression: Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012. Breast Diseases, 24(2), 143-144. https://doi.org/10.1016/j.breastdis.2013.04.044

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression: Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012. / Chavez-Macgregor, M.; Valero, V.
In: Breast Diseases, Vol. 24, No. 2, 2013, p. 143-144.

Research output: Contribution to journal › Comment/debate › peer-review

Chavez-Macgregor, M & Valero, V 2013, 'Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression: Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012', Breast Diseases, vol. 24, no. 2, pp. 143-144. https://doi.org/10.1016/j.breastdis.2013.04.044

Chavez-Macgregor M , Valero V. Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression: Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012. Breast Diseases. 2013;24(2):143-144. doi: 10.1016/j.breastdis.2013.04.044

Chavez-Macgregor, M. ; Valero, V. / Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression : Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012. In: Breast Diseases. 2013 ; Vol. 24, No. 2. pp. 143-144.

@article{dbd98871e453433cb0b94644d78ccbc8,

title = "Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression: Lindstr{\"o}m LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012",

author = "M. Chavez-Macgregor and V. Valero",

year = "2013",

doi = "10.1016/j.breastdis.2013.04.044",

language = "English (US)",

volume = "24",

pages = "143--144",

journal = "Breast Diseases",

issn = "1043-321X",

publisher = "Academic Press Inc.",

number = "2",

}

TY - JOUR

T1 - Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression

T2 - Lindström LS, Karlsson E, Wilking UM, et al (Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; Et al) J Clin Oncol 30:2601-2608, 2012

AU - Chavez-Macgregor, M.

AU - Valero, V.

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84879050448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879050448&partnerID=8YFLogxK

U2 - 10.1016/j.breastdis.2013.04.044

DO - 10.1016/j.breastdis.2013.04.044

M3 - Comment/debate

AN - SCOPUS:84879050448

SN - 1043-321X

VL - 24

SP - 143

EP - 144

JO - Breast Diseases

JF - Breast Diseases

IS - 2

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this